Ocera Therapeutics' Series A Round

Ocera Therapeutics raised a round of funding on January 16, 2006.

Ocera Therapeutics is focused on the development and commercialization of therapeutics for gastrointestinal and liver diseases. The company's portfolio consists of OCR-002 and AST-120. OCR-002 is an a…

Articles about Ocera Therapeutics' Series A Round: